Zomedica Corp [ZOM] stock is trading at $0.14, up 14.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZOM shares have gain 16.28% over the last week, with a monthly amount glided 10.24%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Zomedica Corp [AMEX: ZOM] stock has seen the most recent analyst activity on January 06, 2023, when Dawson James initiated its Buy rating and assigned the stock a price target of $6.
Zomedica Corp [ZOM] stock has fluctuated between $0.12 and $0.23 over the past year. Zomedica Corp [AMEX: ZOM] shares were valued at $0.14 at the most recent close of the market.
Analyzing the ZOM fundamentals
Zomedica Corp [AMEX:ZOM] reported sales of 26.73M for the trailing twelve months, which represents a growth of 10.24%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -1.43%, Pretax Profit Margin comes in at -2.32%, and Net Profit Margin reading is -2.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.28 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1259 points at the first support level, and at 0.1119 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1492, and for the 2nd resistance point, it is at 0.1585.
Ratios To Look Out For
For context, Zomedica Corp’s Current Ratio is 10.82. Further, the Quick Ratio stands at 10.15, while the Cash Ratio is 1.21. Considering the valuation of this stock, the price to sales ratio is 5.13, the price to book ratio is 0.68.
Transactions by insiders
Recent insider trading involved POWERS JOHNNY D, Director, that happened on Nov 11 ’24 when 100000.0 shares were purchased. CEO, HEATON LARRY C II completed a deal on Nov 11 ’24 to buy 100000.0 shares. Meanwhile, Vice President of Sales Klass Russell Kevin bought 0.5 million shares on Nov 11 ’24.
